Back to Market Feed

Product Information

BROMFENAC SODIUM 0.09% EYE DRP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $15.6676 per ML under NDC 68180043601. Its NADAC has been published 123 times since Apr 17, 2024.

FDA first approved this application on Aug 15, 2023. Its Orange Book therapeutic-equivalence code is AT2.

BROMFENAC SODIUM 0.09% EYE DRP

Bromfenac
$15.6676per ML

Strength

.9 mg/mL

NDC

68180043601

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

BROMFENAC SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA202903

FDA Approved

8/15/2023

TE Code

AT2

On Market Since

2/2/2024

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for BROMFENAC SODIUM 0.09% EYE DRP has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 20.3%. The table below summarizes its recorded NADAC range and movement.

Current price$15.6676 per ML
All-time high$24.0921 (Jun 11, 2025)
All-time low$15.1840 (Apr 22, 2026)
52-week high$22.2786
52-week low$15.1840
Median price$20.2795
Average price$20.0805
Largest weekly change+33.5% (Jun 19, 2024)
Weeks tracked123
Tracking sinceApr 17, 2024

Price History

1W

-5.5%

1M

-5.5%

3M

-2.4%

6M

-8.7%

1Y

-26.6%

3Y

N/A

5Y

N/A

All

-20.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Bromfenac market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

MINIPRIN EC 81 MG TABLET
Generic
49483033010•Time-Cap Labs Inc.
$0.0118
per EA
MINIPRIN EC 81 MG TABLET
Generic
49483033012•Time-Cap Labs Inc.
$0.0118
per EA
QC ASPIRIN 325 MG TABLET
Generic
63868035203•Chain Drug Marketing Association
$0.0121
per EA
QC ASPIRIN 325 MG TABLET
Generic
63868035210•Chain Drug Marketing Association
$0.0121
per EA
ST. JOSEPH ASPIRIN EC 81 MG TB
Generic
69536018112•Foundation Consumer Healthcare LLC
$0.0139
per EA
ASPIRIN EC 81 MG TABLET
Generic
00536123441•Rugby Laboratories
$0.0146
per EA
ASPIRIN EC 81 MG TABLET
Generic
00904675180•Major Pharmaceuticals
$0.0146
per EA
ASPIRIN EC 81 MG TABLET
Generic
00904678370•Major Pharmaceuticals
$0.0146
per EA
GNP ASPIRIN EC 81 MG TABLET
Generic
46122059848•AmerisourceBergen
$0.0146
per EA
GNP ASPIRIN EC 81 MG TABLET
Generic
46122059887•AmerisourceBergen
$0.0146
per EA

Frequently asked questions

What is the NADAC price of BROMFENAC SODIUM 0.09% EYE DRP?

The current National Average Drug Acquisition Cost (NADAC) for BROMFENAC SODIUM 0.09% EYE DRP, manufactured by Lupin Pharmaceuticals Inc., is $15.6676 per ML (NDC 68180043601), effective Aug 19, 2026.

How has the price of BROMFENAC SODIUM 0.09% EYE DRP changed over time?

Over the history we have for it, the NADAC for BROMFENAC SODIUM 0.09% EYE DRP has declined 20.3%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for BROMFENAC SODIUM 0.09% EYE DRP?

Since Apr 17, 2024, the NADAC for BROMFENAC SODIUM 0.09% EYE DRP has ranged from a low of $15.1840 (Apr 22, 2026) to a high of $24.0921 (Jun 11, 2025), with a median of $20.2795 per ML.

Are there cheaper alternatives to BROMFENAC SODIUM 0.09% EYE DRP?

No other NADAC-published product currently shares the active ingredient and strength of BROMFENAC SODIUM 0.09% EYE DRP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BROMFENAC SODIUM 0.09% EYE DRP?

BROMFENAC SODIUM 0.09% EYE DRP (NDC 68180043601) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.